Data_Sheet_1_Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis.PDF
Recent observational studies have explored the association between non-alcoholic fatty liver disease (NAFLD) and stroke with controversial results. We therefore performed a meta-analysis to investigate this possible association.
MethodsPubMed, EMBASE and Web of Science database were searched from inception until December 2019, and updated on May 2021. Random-effects meta-analyses were performed by generic inverse variance method. Subgroup and sensitivity analyses were also conducted. The PROSPERO registered number of this study is CRD42020167330.
ResultsTwenty observational (15 cohort, 4 cross-sectional, and 1 case-control) studies with 17,060,388 participants were included in the meta-analysis. Meta-analysis of data from 18 studies with 17,031,672 participants has shown that NAFLD was associated with mildly increased risk of stroke (OR = 1.18, 95% CI: 1.08–1.30, P = 0.0005). Similar results were observed in most of the subgroup analyses we performed. Sensitivity analyses did not alter these findings. Meta-analysis of data from 3 studies with 29,614 participants has shown that insufficient evidence to support the proposed association between NAFLD-fibrosis and an increased risk of stroke.
ConclusionsWe found that NAFLD was associated with increased risk of stroke. However, there was insufficient evidence to support the proposed association between NAFLD-fibrosis and an increased risk of stroke. To better understand any association, future well-designed prospective studies that take fully account of specific population, type of stroke, and confounding factors are warranted.
Systematic Review RegistrationUnique Identifier: CRD42020167330.
History
References
- https://doi.org//10.1002/hep.28431
- https://doi.org//10.1016/S2468-1253(19)30039-1
- https://doi.org//10.1002/hep.29367
- https://doi.org//10.1016/j.cell.2021.04.015
- https://doi.org//10.1002/hep.28785
- https://doi.org//10.1002/hep.30251
- https://doi.org//10.1016/j.jhep.2016.05.013
- https://doi.org//10.1016/j.metabol.2018.06.004
- https://doi.org//10.1016/j.metabol.2017.11.003
- https://doi.org//10.1016/S1474-4422(19)30034-1
- https://doi.org//10.1016/S0140-6736(16)30962-X
- https://doi.org//10.3748/wjg.v13.i10.1579
- https://doi.org//10.1097/MCG.0b013e31822fb3f7
- https://doi.org//10.1016/j.jsha.2013.07.004
- https://doi.org//10.2214/AJR.13.11367
- https://doi.org//10.1016/j.atherosclerosis.2016.01.016
- https://doi.org//10.1371/journal.pone.0194153
- https://doi.org//10.1111/liv.13663
- https://doi.org//10.1001/jamaneurol.2017.3229
- https://doi.org//10.1136/bmj.l5367
- https://doi.org//10.14309/ajg.0000000000000401
- https://doi.org//10.1111/liv.13973
- https://doi.org//10.1016/j.jns.2019.116524
- https://doi.org//10.1016/j.cgh.2019.12.026
- https://doi.org//10.1007/s10620-019-05986-9
- https://doi.org//10.3390/ijerph17249568
- https://doi.org//10.3389/fendo.2021.638615
- https://doi.org//10.1016/j.cgh.2020.12.022
- https://doi.org//10.1016/j.jstrokecerebrovasdis.2021.105788
- https://doi.org//10.1161/STROKEAHA.120.030433
- https://doi.org//10.1136/bmj.b2535
- https://doi.org//10.1007/s10654-010-9491-z
- https://doi.org//10.1186/1471-2458-13-154
- https://doi.org//10.14309/ajg.0000000000000500
- https://doi.org//10.1136/bmj.39489.470347.AD
- https://doi.org//10.1016/0197-2456(86)90046-2
- https://doi.org//10.1001/jamanetworkopen.2019.20964
- https://doi.org//10.1136/bmj.327.7414.557
- https://doi.org//10.1136/bmj.d4002
- https://doi.org//10.2307/2533446
- https://doi.org//10.1136/bmj.315.7109.629
- https://doi.org//10.1016/j.dsx.2016.12.033
- https://doi.org//10.18632/oncotarget.22755
- https://doi.org//10.1097/EDE.0b013e3181feb50a
- https://doi.org//10.1002/hep.20466
- https://doi.org//10.1016/j.diabet.2020.101215
- https://doi.org//10.1111/apt.16575
- https://doi.org//10.4254/wjh.v10.i7.474
- https://doi.org//10.1038/nrgastro.2017.109
- https://doi.org//10.1016/j.jhep.2008.11.017
- https://doi.org//10.1016/j.atherosclerosis.2015.02.011
- https://doi.org//10.1002/hep.24452
- https://doi.org//10.1186/1471-230X-6-33
- https://doi.org//10.1016/j.jhep.2012.11.021
- https://doi.org//10.1136/bmj.l6495
- https://doi.org//10.1016/j.atherosclerosis.2017.02.005
- https://doi.org//10.1016/j.atherosclerosis.2018.06.876